Status:
UNKNOWN
Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
Lead Sponsor:
Medical University of Vienna
Conditions:
Dyslipidemia
Atherosclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Dyslipidaemia is characterized by low plasma levels of high-density lipoprotein cholesterol (HDL-c), elevated triglycerides and an increase in low density lipoprotein (LDL-c) particles, and has been u...
Eligibility Criteria
Inclusion
- PAD defined as an ABI ≤0.9 or \>1.3 in patients with low serum HDL cholesterol levels (\<45mg/dL in men, \<55 mg/dL in women)
Exclusion
- Elevated liver enzymes (above 2 times the normal level)
- Skeletal muscle myopathy or elevated serum CK levels
- Allergy or hypersensibility to either statins or nicotinic acid
- Women of childbearing potential
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00712049
Start Date
June 1 2008
Last Update
July 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna
Vienna, Austria, 1090